PROGRAMMES

Discover our current research programme, which highlights our commitment to groundbreaking studies and treatments, based on our expertise in iron metabolism and cell cycle biology.

At Pharmacosmos, we are committed to scientific progress in iron metabolism and blood-related disorders. Our research includes clinical studies aimed at expanding knowledge and exploring potential new treatment approaches. Through these programmes, we seek to contribute to the long-term understanding and management of these conditions.

Clinical Trials

Explore our clinical trials.

Petadeferitrin

Pharmacosmos is developing petadeferitrin, a small molecule iron chelator, as a potential new treatment for patients with transfusional iron overload.